Tower Research Capital (TRC)’s Ambipar Emergency Response Warrants AMBI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-26
Closed -$8 5156
2024
Q4
$8 Hold
26
﹤0.01% 5627
2024
Q3
$8 Hold
26
﹤0.01% 5636
2024
Q2
$5 Hold
26
﹤0.01% 5614
2024
Q1
$8 Hold
26
﹤0.01% 5785
2023
Q4
$10 Hold
26
﹤0.01% 5845
2023
Q3
$12 Hold
26
﹤0.01% 5847
2023
Q2
$13 Hold
26
﹤0.01% 5940
2023
Q1
$0 Buy
+26
New +$11 ﹤0.01% 5768

Other funds holding AMBI.WS

Tower Research Capital (TRC)'s AMBI.WS Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Ambipar Emergency Response Warrants (AMBI.WS) in Q1 2025, closing a stake of 26 shares — an estimated $8 sold.

Tower Research Capital (TRC) first reported a position in AMBI.WS in Q1 2023 and held it in 8 quarters. The position peaked at $13 in Q2 2023. 12 funds tracked by Wall St. Rank hold AMBI.WS as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Ambipar Emergency Response Warrants position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 26 Ambipar Emergency Response Warrants shares in Q1 2025, an estimated $8.
  • Tower Research Capital (TRC) first reported a position in Ambipar Emergency Response Warrants in Q1 2023 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s Ambipar Emergency Response Warrants position peaked at $13 in Q2 2023.
  • 12 funds tracked by Wall St. Rank held Ambipar Emergency Response Warrants as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.